We conducted a study to ascertain Mantoux reaction among diabetic patients. Since we conducted the work in a diabetic clinic, we found it difficult to blind the subjects (from investigators or independent investigators too) as they were from a diabetic clinic, thus all of them being diabetic. To mitigate this, we took steps to standardize all administration and TST reading based on CDC guidelines. We were blinded to other information such as investigative results and other history on comorbities. Being aware that this is some form of inescapable bias, is this still permissible or is the study method flawed?